Bio Pharma Dive
MAY 22, 2025
Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.
Intouch Solutions
MAY 21, 2025
At EVERSANA INTOUCH, we are excited to announce leadership appointments that will directly benefit our pharmaceutical clients. These changes are designed to enhance our ability to deliver value-led advertising, market access, media, medical communications, and transformation solutions, ensuring that our clients receive unparalleled impact and strategic excellence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 16, 2025
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.
Medical Xpress
MAY 17, 2025
A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to research presented at Heart Failure 2025.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.
pharmaphorum
MAY 16, 2025
In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation
ACRP blog
MAY 16, 2025
In recognition of Asian American, Native Hawaiian, and Pacific Islander ( AANHPI ) Heritage Month this May, ACRP asked Sharleen Traynor, PhD, MPH, ACRP-CP, Director of the Clinical Trials Research Associate Program at Durham Technical Community College in North Carolina, to share her thoughts on the importance that AANHPI heritage has had in her life and more broadly in the clinical research enterprise, both for participants and professionals.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 16, 2025
The deal gives Lilly access to the companys RNA-editing platform to develop therapies for sensorineural hearing loss.
Medical Xpress
MAY 17, 2025
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.
pharmaphorum
MAY 16, 2025
Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle
Bio Pharma Dive
MAY 16, 2025
Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Pharmaceutical Technology
MAY 16, 2025
The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April.
Medical Xpress
MAY 17, 2025
University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for rapid hemostasis and tissue adhesion in soft, elastic organs.
XTalks
MAY 22, 2025
On May 20, 2025, Kettering Health experienced a system-wide technology outage caused by a ransomware attack , disrupting services across its 14 medical centers in Ohio. The incident led to the cancellation of elective inpatient and outpatient procedures, disabled the systems call center and interrupted access to patient portals such as MyChart. Emergency rooms and outpatient clinics remain open.
Pharma Marketing Network
MAY 16, 2025
In today’s digital landscape, the integration of artificial intelligence (AI) into healthcare social media marketing is revolutionizing how organizations engage with patients and professionals. As AI technologies become more sophisticated, they offer unprecedented opportunities to personalize content, predict trends, and optimize campaigns. This evolution is not just a trend but a fundamental shift in how healthcare entities communicate and build trust with their audiences.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
MAY 16, 2025
The deal “fits like a glove” for BioMarin’s business, according to an analyst who also thinks there could be a “valuable” market opportunity for Inozyme’s main drug.
Pharmaceutical Technology
MAY 16, 2025
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
Medical Xpress
MAY 17, 2025
Feel like you can't focus? Like you'll never finish a book again? Like the only way to keep your mind and hands busy is to scroll on social media for hours?
XTalks
MAY 22, 2025
Diabetes affects hundreds of millions worldwide currently, about 537 million people live with the condition, with projections reaching nearly 643 million by 2030. These figures underline the urgency for novel and more effective treatment strategies, particularly for type 1 diabetes (T1D). Although T1D accounts for only about 5% to 10% of all diabetes cases , its onset at a young age and the need for lifelong management present unique challenges.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 18, 2025
The FDA has approved the first blood test for Alzheimer's disease based on a blood test from Fujirebio in a step forward for early diagnosis
Bio Pharma Dive
MAY 16, 2025
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.
Velocity Clinical Research
MAY 22, 2025
Henrik Watz, MD, PhD, presented compelling real-world data at the American Thoracic Society Annual Meeting on the long-term impact of dupilumab therapy in patients with severe asthma. Participants in the ProVENT study experienced sustained improvements in lung function, asthma control, and quality of life. Notably, more than half achieved asthma remission within two years of treatment.
Medical Xpress
MAY 17, 2025
Ancestry and lifestyle choices of parents may affect the rate and type of new genetic changes that arise in their children, new research has found.
XTalks
MAY 22, 2025
Observed each year on May 24, World Schizophrenia Awareness Day shines a light on one of the most misunderstood mental health conditions. Schizophrenia is a chronic psychiatric disorder that alters how individuals perceive reality, think and relate to others. Symptoms are typically categorized as positive (hallucinations, delusions), negative (emotional withdrawal, social disconnection) or cognitive (memory or attention deficits).
pharmaphorum
MAY 18, 2025
FDA finally okays Novavax's COVID-19 jab, with restrictions Phil.
Bio Pharma Dive
MAY 22, 2025
The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off versions that have dented its sales forecasts.
Drug Discovery World podcast
MAY 22, 2025
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation withPhil L’Huillier, CEO of Scancell. Following the companys recent partnership with the NHS Cancer Vaccine Launch Pad, enabling fast-tracked access for melanoma patients, we discuss how Scancell is addressing the scientific, clinical, and logistical challe
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Medical Xpress
MAY 17, 2025
Researchers at the University of Tsukuba investigated whether monoamine neurotransmitters, such as dopamine, are involved in hippocampal activation even during light exercise. Dopamine secreted from the ventral tegmental area of the brainstem and noradrenaline secreted from the locus coeruleus were hypothesized to be involved in a brain neural circuit that regulates hippocampal activation during light exercise.
XTalks
MAY 22, 2025
In this episode, Ayesha speaks with Ebrahim S. Delpassand, MD, Founder and CEO of RadioMedix , a company developing innovative radiopharmaceuticals for cancer diagnosis, monitoring and treatment. With a focus on both PET imaging and therapeutic radiopharmaceuticals labeled with alpha and beta emitters, RadioMedix is helping to shape the future of precision oncology.
Pharmaceutical Commerce
MAY 16, 2025
In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.
Bio Pharma Dive
MAY 22, 2025
An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs bought a startup.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Expert insights. Personalized for you.
159 
Let's personalize your content